Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C
- PMID: 35772010
- PMCID: PMC10336699
- DOI: 10.1080/00952990.2022.2082301
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C
Abstract
Background: Medications for opioid use disorder (MOUDs) are the gold standard for OUD treatment but are underused. To our knowledge, no published study has systematically identified and categorized state policy innovations for expanding MOUD utilization.Objective: We sought to identify and categorize state MOUD policy innovations.Methods: Within a stratified random sample of 16 U.S. states and Washington D.C. we searched for 2019 state statutes and regulations related to MOUD in Westlaw legal database. We then identified laws that appeared designed to increase MOUD utilization and categorized them using a template analysis approach.Results: We found 82 laws with one or more MOUD expansion policies. We identified six high-level MOUD expansion policy categories: 1) policies expanding the availability of waivered buprenorphine providers; 2) needs assessments and policies increasing public MOUD awareness; 3) criminal justice system policies; 4) Substance use disorder (SUD) treatment and sober living facility policies; 5) insurance policies; and 6) hospital policies. SUD treatment and housing facility policies, as well as insurance policies, were most common.Conclusions: Multipronged approaches are being pursued by several states to increase MOUD access. Our results can inform policymakers of MOUD expansion approaches in other jurisdictions. Policy categories can serve as the basis for policy variables for future analyses of policy effects.
Keywords: buprenorphine; criminal justice; insurance; law; medications for opioid use disorder; methadone; opioid use disorder; policy; qualitative; state.
Conflict of interest statement
Figures
Similar articles
-
Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.Subst Abus. 2022;43(1):425-432. doi: 10.1080/08897077.2021.1944958. Epub 2021 Jul 8. Subst Abus. 2022. PMID: 34236297 Free PMC article.
-
Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019.Ann Med. 2023 Dec;55(1):514-520. doi: 10.1080/07853890.2023.2171107. Ann Med. 2023. PMID: 36724766 Free PMC article.
-
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).J Subst Abuse Treat. 2021 Sep;128:108275. doi: 10.1016/j.jsat.2021.108275. Epub 2021 Jan 8. J Subst Abuse Treat. 2021. PMID: 33483222 Free PMC article.
-
Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application.J Subst Use Addict Treat. 2024 Oct;165:209441. doi: 10.1016/j.josat.2024.209441. Epub 2024 Jun 19. J Subst Use Addict Treat. 2024. PMID: 38906417 Free PMC article. Review.
-
Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.JAMA Pediatr. 2022 Mar 1;176(3):304-311. doi: 10.1001/jamapediatrics.2021.4606. JAMA Pediatr. 2022. PMID: 34870707 Free PMC article.
Cited by
-
Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties.Epidemiology. 2024 May 1;35(3):418-429. doi: 10.1097/EDE.0000000000001703. Epub 2024 Feb 19. Epidemiology. 2024. PMID: 38372618 Free PMC article.
-
Effects of state opioid prescribing laws on rates of fatal crashes in the USA.Inj Prev. 2025 Jan 23;31(1):21-27. doi: 10.1136/ip-2023-045159. Inj Prev. 2025. PMID: 38719440 Free PMC article.
-
Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009-2018.Drug Alcohol Depend Rep. 2023 Oct 11;9:100193. doi: 10.1016/j.dadr.2023.100193. eCollection 2023 Dec. Drug Alcohol Depend Rep. 2023. PMID: 37876376 Free PMC article.
-
Prosecuting overdose: An exploratory study of prosecutorial motivations for drug-induced homicide prosecutions in North Carolina.Int J Drug Policy. 2024 Mar;125:104344. doi: 10.1016/j.drugpo.2024.104344. Epub 2024 Feb 10. Int J Drug Policy. 2024. PMID: 38342051 Free PMC article.
-
State Policy Variation in Implementation of Federal Drug and Child Abuse Laws and Stigmatization of Pregnant and Postpartum Individuals with Opioid Use Disorder.J Womens Health (Larchmt). 2025 May;34(5):613-621. doi: 10.1089/jwh.2024.0638. Epub 2025 Feb 11. J Womens Health (Larchmt). 2025. PMID: 39932704
References
-
- Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose death counts.: National Center for Health Statistics; 2021. [Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation.
-
- National Academies of Science Engineering & Medicine. Medications for Opioid Use Disorder Save Lives Washington D.C.: The National Academies Press; 2019. - PubMed
-
- Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2021. Contract No.: HHS Publication No. PEP21-07-01-003, NSDUH Series H-56.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical